Vantictumab Biosimilar – Anti-FZD mAb – Research Grade

Reference:
Product nameVantictumab Biosimilar - Anti-FZD mAb - Research Grade
SourceCAS 1345009-45-1
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsVantictumab,OMP-18R5,FZD,anti-FZD
ReferencePX-TA1329
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG2-lambda
ClonalityMonoclonal Antibody

Description of Vantictumab Biosimilar - Anti-FZD mAb - Research Grade

General information on Anti-FZD[Homo sapiens] (Vantictumab) Monoclonal Antibody

Vantictumab has beeninvestigated for the treatment of Solid Tumors and Pancreatic Cancer.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Vantictumab Biosimilar – Anti-FZD mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CD344 Recombinant Protein
Antigen

CD344 Recombinant Protein

PX-P4122 310€
CD344 / FZD4, C-His, recombinant protein
Antigen

CD344 / FZD4, C-His, recombinant protein

PX-P5620 385€
Stable Isotope Labelled Vantictumab Biosimilar – Anti-FZD mAb – Research Grade
SIL

Stable Isotope Labelled Vantictumab Biosimilar – Anti-FZD mAb – Research Grade

PX-TA1329-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products